TPR and acute respiratory distress syndrome: To give just one example, thromboxane (Tx) biosynthesis is markedly elevated in patients with acute respiratory distress syndrome (ARDS) and preclinical studies have shown that Tx receptor (TPr) antagonism prevents the evolution of a lipopolysaccharide (LPS)-induced syndrome of ARDS in sheep (Kühl et al., 1988).